Ilaprazole
From Infogalactic: the planetary knowledge core
250px | |
Systematic (IUPAC) name | |
---|---|
2-[(RS)-[(4-methoxy-3-methylpyridin-2-yl)methyl]sulfinyl]-5-(1H-pyrrol-1-yl)-1H-benzimidazole
|
|
Clinical data | |
Trade names | Noltec |
Routes of administration |
Oral |
Identifiers | |
CAS Number | 172152-36-2 |
ATC code | None |
PubChem | CID: 214351 |
ChemSpider | 185839 |
UNII | 776Q6XX45J ![]() |
ChEMBL | CHEMBL2106370 |
Chemical data | |
Formula | C19H18N4O2S |
Molecular mass | 366.436820 g/mol |
|
|
|
Ilaprazole (trade name Noltec) is a proton pump inhibitor (PPI) used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and duodenal ulcer. It is available in strengths of 5, 10, and 20 mg.
Clinical studies show that ilaprazole is at least as potent a PPI as omeprazole when taken in equivalent doses. Studies also showed that ilaprazole significantly prevented the development of reflux oesophagitis.
Ilaprazole is developed by Il-Yang Pharmaceutical (Korea), and is still under clinical trials with US FDA. It has launched in Korea and China for the treatment of gastric ulcer, duodenal ulcer, gastroesophageal reflux disease and erosive esophagitis.[1]
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
Categories:
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Benzimidazoles
- Proton pump inhibitors
- Pyridines
- Pyrroles
- Sulfones